Trials / Unknown
UnknownNCT05378009
Functional Dyspepsia Response to Relaxation Therapy and Physical Activity
Functional Dyspepsia Response to Relaxation Therapy Alone or Combined With Physical Activity
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 40 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Functional dyspepsia (FD) is a common gastrointestinal disease with high morbidity. Due to the drop in estrogen level, perimenopausal women with FD (PMFD) have an increase in emotional disorders such as depression, anxiety and sleep disorder.
Detailed description
the research will include 30 FD women during their perimenopause to receive for 8 weeks the following: relaxation therapy (Benson relaxation), physical exercise (on treadmill), and proton pump inhibitors. Also, the research will include another 30 FD women during their perimenopause to receive for 8 weeks the following: relaxation therapy (Benson relaxation) and proton pump inhibitors
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | relaxation and physical activity | This FD women group will include 30 females who will be treated for 8 weeks with oral proton pump inhibitors (taken one time daily with 40 mg pantoprazole-tablet dose), Benson relaxation daily sessions (twenty minutes at morning time and another 20 minutes at the evening time), physical activity ( five session per the week conducted on treadmill, 30 minutes in the first treatment month and 40 minutes in the second treatment month) |
| BEHAVIORAL | relaxation | This FD women group will include 30 females who will be treated for 8 weeks with oral proton pump inhibitors (taken one time daily with 40 mg pantoprazole-tablet dose) and Benson relaxation daily sessions (twenty minutes at morning time and another 20 minutes at the evening time) |
Timeline
- Start date
- 2022-03-01
- Primary completion
- 2022-06-15
- Completion
- 2022-06-15
- First posted
- 2022-05-17
- Last updated
- 2022-05-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05378009. Inclusion in this directory is not an endorsement.